Scientists at Cleveland Clinic, Riken, and IBM (IBM) have used IBM quantum computers and two supercomputers to simulate protein complexes spanning up to 12,635 atoms. The companies said these are the largest-known simulations of biologically meaningful molecules performed with quantum hardware yet, and signal that quantum computers are maturing into useful scientific tools which can help solve fundamental problems in biology, chemistry, and life sciences. The results were achieved in part by an innovative algorithm that optimizes how quantum and classical computers can work together, a framework known as quantum-centric supercomputing. Using this approach, the team captured the behavior of two biochemically relevant proteins that are roughly 40 times larger than what this same method could initially achieve just six months ago. Additionally, the accuracy of the simulations in a key step of the workflow improved by up to 210 times over this same period. “For years, quantum computing has been a promise. Now, quantum computers are producing results that matter to science,” said Jay Gambetta, director of IBM Research and IBM Fellow. “The systems we simulated here are the kind of molecules that biologists and chemists work with in the real world. Quantum computers are no longer proving they are viable tools – they are proving they can contribute meaningful results in quantum-centric supercomputing architectures.”
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade IBMPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- IBM announces private preview for IBM Cyber Fraud solution
- The Week That Was, The Week Ahead: Macro and Markets, May 3
- IBM Shareholders Endorse Board, Pay and Incentive Plan
- 3 Top Dividend Aristocrat Stocks That Could Hand Investors 20%+ Returns
- IBM Is Bringing AI and Quantum Computing to Race Car Design
